Heartsbreath Test for Heart Transplant Rejection

UnknownOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2013

Study Completion Date

September 30, 2016

Conditions
Heart Transplant Rejection
Interventions
DEVICE

BreathScanner 1.0

For the HeartsBreath test, breath is collected using BreathScanner 1.0 and sent to central laboratory for analysis for markers of transplant rejection.

DEVICE

BreathLink

The BreathLink point-of-care system detects and quantifies the breath VOC's determined to be biomarkers during the development of the Heartsbreath test.

Trial Locations (5)

10032

Columbia Presbyterian Medical Center, New York

19102

Hahnemann University Hospital and the Drexel University College of Medicine, Philadelphia

90211

Cedars-Sinai Medical Center, Beverly Hills

94305-5406

Stanford University School of Medicine, Stanford

07112

Newark Beth Israel Medical Center, Newark

Sponsors
All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Menssana Research, Inc.

INDUSTRY

NCT01397812 - Heartsbreath Test for Heart Transplant Rejection | Biotech Hunter | Biotech Hunter